Navigation Links
Second Successful Quigley QR-443 Study Suggests Method of Action,Relevant to Broad Range of Chronic Inflammatory Diseases - Human,Study to Follow -

DOYLESTOWN, Pa., June 20, 2007 /PRNewswire-FirstCall/ -- Quigley Pharma, www.QuigleyPharma.com, a wholly owned subsidiary of The Quigley Corporation announced today that it has completed a follow-up study to evaluate the impact of QR-443 on levels of a pro-inflammatory cytokine Interleukin-6 (IL-6) in a cachexia model. This new data concluded that responding mice had lower levels of serum IL-6 when administered QR-443 orally than mice that received placebo. This reduction in IL-6 suggests a method of action for the delayed onset and reduced severity of cachexia observed in this study as well as the previously conducted cachexia model study.

QR-443 was formulated with the intention to impact metabolic imbalances and chronic inflammation. Cachexia is an extremely debilitating and life threatening, wasting syndrome associated with chronic diseases such as cancer, AIDS, chronic renal failure, COPD and rheumatoid arthritis, where inflammation has a significant impact and patients experience loss of weight, muscle atrophy, fatigue, weakness and decreased appetite.

A reduction in IL-6 is associated with a reduction in inflammation and suggests that QR-443 may have a role in a broad range of chronic inflammatory diseases. The Company has begun developing a human study protocol to evaluate the safety and impact of this compound on specific metabolic processes altered by chronic inflammation and the presence of IL-6.

Chronic inflammation is also associated with other disorders such as rheumatoid arthritis, metabolic syndrome, COPD, AIDS and cancer and can cause physical, metabolic and physiological limitations. Interleukin-6 (IL-6) is a pro-inflammatory cytokine secreted to stimulate an immune response to trauma and disease leading to inflammation. Inflammation and the presence of IL-6 have been shown to negatively effect "normal" metabolic
'"/>




Page: 1 2 3 4

Related medicine technology :

1. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
2. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
3. Second Phase III Study Evaluating Gileads Viread for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint
4. NeurogesX Announces Presentation of Positive Phase 3 Clinical Data at the Second International Congress on Neuropathic Pain Meeting (NeuPSIG)
5. Repros Androxal Shows Highly Statistically Significant Positive Effects in Men with Secondary Hypogonadism
6. Pharmions Amrubicin Shows Encouraging Results Compared to Standard of Care in Second Line Treatment of Small Cell Lung Cancer
7. Positive Results for Second-Generation Taxus Liberte Coronary Stent System Highlighted in Journal of American College of Cardiology
8. Kosan Presents Promising Phase 1 Data on Second-Generation Hsp90 Inhibitor, Alvespimycin, Showing Antitumor Activity in Refractory Breast and Ovarian Cancers at ASCO
9. Gilead Announces Achievement of Primary Efficacy Endpoint in Second Phase III Study of Aztreonam Lysine for Inhalation in Patients With Cystic Fibrosis
10. Amlodipine and Olmesartan Study Results Released;Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
11. Amlodipine and Olmesartan Study Results Released; Late Breaker Presented at American Society of Hypertension Twenty-Second Annual Scientific Meeting (ASH 2007)
Post Your Comments:
(Date:9/19/2014)... 2014 UBM Medica US announces that  ... to help oncologists and other clinicians gain a better ... of targeted therapies and immunotherapies, discusses some of the ... Every September, Blood Cancer Awareness Month ... about blood cancers—helping to increase survival rates and improve ...
(Date:9/19/2014)... , Sept. 19, 2014  Pressure BioSciences, ... announced it has received and approved all parts ... instruments and has begun to manufacture the new ... instrument will be ready for shipment by mid-October ... and released at a rate of about one ...
(Date:9/19/2014)... , Sept. 19, 2014  Over 200 runners participated ... to Benefit the Radiation Oncology Institute (ROI), hosted by ... Golden Gate Park in San Francisco.  ... , CEO of Radiation Business Solutions, "but at ... raised over $70,000 for the ROI this year. This ...
Breaking Medicine Technology:OncoTherapy Network Highlights National Blood Cancer Awareness Month 2OncoTherapy Network Highlights National Blood Cancer Awareness Month 3OncoTherapy Network Highlights National Blood Cancer Awareness Month 4Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 2Pressure BioSciences Announces Completion of the First Phase of Its Commercialization Plan for the Barozyme HT48, the Company's Recently Released High Throughput PCT-based Instrument System 3Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 2Fifth Annual 5K Run for the Future to Benefit the Radiation Oncology Institute Breaks Attendance, Donation Records 3
... DEERFIELD, IL, June 04, 2007,/PRNewswire-FirstCall/ - Cardiome ... US, Inc. ("Astellas") today,announced results from their ... 2. The trial evaluated the efficacy and ... (iv)") for the treatment of patients who ...
... -- ZymoGenetics,Inc. today announced that interim findings were ... in B-cell chronic,lymphocytic leukemia (B-CLL) at the American ... study included intravenous,administration of higher doses than had ... atacicept was well-tolerated and biologically,active at all dose ...
Cached Medicine Technology:Cardiome And Astellas Announce Positive Results From ACT 2 Trial 2Cardiome And Astellas Announce Positive Results From ACT 2 Trial 3Cardiome And Astellas Announce Positive Results From ACT 2 Trial 4Cardiome And Astellas Announce Positive Results From ACT 2 Trial 5Cardiome And Astellas Announce Positive Results From ACT 2 Trial 6ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3
(Date:9/20/2014)... RBSEO Services, which has occupied a top ... it provides an affordable website SEO (Search Engine Optimization) ... would benefit those new and old businesses struggling to ... to pay a big amount for their website promotion. ... in top search results for their business keywords and ...
(Date:9/20/2014)... September 20, 2014 The first federal ... now in its third week in the U.S. District ... reports. Court documents indicate that the week opened in ... testimony from a DePuy Orthopaedics vice president, who discussed ... the company’s Pinnacle hip replacement. According to Reuters, the ...
(Date:9/20/2014)... 2014 The children of Branches now ... active play they need. An empty lot at the ... Campus was transformed into a kid-designed playspace in less ... from Branches (@BranchesFL), ESPN (@TeamESPN), Disney (@CitizenDisney), area residents ... a playground is more than a playground. It’s a ...
(Date:9/19/2014)... 2014 “Copay coupons,” a drug manufacturer ... drugs among patients with prescription drug coverage, may now ... new report from the Department of Health and ... anti-kickback laws prohibit suppliers from offering side-payments to increase ... government. , The report highlights that two recent surveys, ...
(Date:9/19/2014)... Dallas, TX (PRWEB) September 19, 2014 ... equipment and solutions, today detailed the key role ... by two-way radios in the healthcare industry. ... operations and patient care – and in emergency ... the difference between life and death,” said Hugh ...
Breaking Medicine News(10 mins):Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 2Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 3Health News:Third Week of DePuy Pinnacle Hip Lawsuit Trial Focuses on Clinical Testing of Metal-on-Metal Hip Implant, Wright & Schulte LLC Reports 4Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 2Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 3Health News:Volunteers Improve Miami Kids’ Lives and Futures with Play 4Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 2Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 3Health News:BearCom Releases Guidelines on Using Two-Way Radios to Improve Communications and Enhance Patient Service in Healthcare 4
... show crying patterns that mimic parents, language, study finds ... are just a few days old cry with intonation ... new research shows. , The conclusion drawn by German ... mothers during the last trimester of pregnancy, laying the ...
... , Iowa and national campaign finance watchdogs ask: Who ... Sen. Chuck Grassley (R) has raised $154,350 in campaign ... care interests, including $43,590 from health insurance interests, according ... Campaign Action Fund. Grassley serves as the ranking Republican ...
... ChemSW is pleased to announce their standing in ... that offers quick, confidential performance ratings and comparisons of ... rated vendor overall in their Q3 2009 Customer Satisfaction ... where the customer satisfaction score was the lowest ever ...
... , From their very first days, newborns, cries already bear the ... published online on November 5th in Current Biology , a ... elements of what will be their first language in the womb, ... dramatic finding of this study is that not only are human ...
... VenaCure-EVLT.com ... ... (NASDAQ: ANGO) launched a new Web site at the American College of Phlebology,s 23rd ... of venous disease. It also features content targeted to patients, including a physician locator ...
... of recent hospital patients commissioned by TransUnion found that two-thirds ... their hospital bill while only three in 10 of those ... programs. , The results of the survey are ... healthcare patient payment estimator at the HFMA Revenue Cycle Strategy ...
Cached Medicine News:Health News:Fetus Learns Intonations of Mother's Tongue 2Health News:Fetus Learns Intonations of Mother's Tongue 3Health News:Sen. Grassley Raised More Than $150,000 Over the Summer From Health Care and Insurance Interests 2Health News:ChemSW Rated Top Vendor Overall for Customer Satisfaction in Q3 2009 by VendorRate 2Health News:Babies' language learning starts from the womb 2Health News:New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 2Health News:New Web Site on Varicose Veins is Launched by AngioDynamics at American College of Phlebology Congress 3Health News:TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 2Health News:TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 3Health News:TransUnion Survey Finds Patients Want More Transparency in Hospital Bills and Knowledge of Charity Care Programs 4
... SC Strep A is a rapid point-of-care ... Strep A antigen in throat swab specimens. ... use no mixing, measuring or working ... cassette format and clearly visible result window ...
... A Twist Rapid Test Device (Throat Swab) is ... a patented design to provide convenience to the ... swab chamber, eliminating the need for test tubes ... exhibits a 93% accuracy compared to plate culture, ...
... Since 1994 the CoaguChek System has been ... needed most, at the point of care. , ... for thousands of patients self-testing when monitoring on ... the user to obtain a result from a ...
... Ovulation Tests are qualitative immunoassays for detecting elevated ... procedure is fast and results are easy to ... is darker than the control band, then ovulation ... If the test band does not appear ...
Medicine Products: